| Pharmaceutical active ingredients: |
| Framycetin SulfateNaphazoline Nitrate |
| Available forms, composition and doses of Soframycine Naphazoline: |
| N / A |
| Soframycine Naphazoline medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA08 - NaphazolineR01AB02 - NaphazolineR01AX08 - FramycetinS01AA07 - FramycetinS01GA01 - NaphazolineS01GA51 - Naphazoline, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sinrinal | Framycetin Sulfate; Hydrocortisone; Lidocaine Hydrochloride; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Solvay |
| Leukase N Gel | Framycetin Sulfate; Lidocaine Hydrochloride | Dermapharm |
| Leukase-Kegel | Framycetin Sulfate; Lidocaine Hydrochloride; Trypsin | Merck |
| Neoparyl Framycetine | Framycetin Sulfate; Meglumine Heparinate; Phenylephrine | Novartis |
| Sofraline | Framycetin Sulfate; Naphazoline Nitrate | Sanofi-Aventis |
| Sofrasolone | Framycetin Sulfate; Naphazoline Nitrate; Prednisolone Acetate | Sanofi-Aventis |
| Dulcimyxine | Framycetin Sulfate; Polymyxin B Sulfate | Allergan |
| Novomyxine | Framycetin Sulfate; Polymyxin B Sulfate | Thea Laboratoires |
| Polyfra-POS | Framycetin Sulfate; Polymyxin B Sulfate; Synephrine Hydrochloride | Ursapharm Arzneimittel |
| Polyfra | Framycetin Sulfate; Polymyxin B Sulfate; Synephrine Tartrate | Alcon |